Skip to main content
Linda Burns, MD, Oncology, Minneapolis, MN

LindaJeanBurnsMD

Oncology Minneapolis, MN

Hematologic Oncology

Professor, Medicine, University of Minnesota Medical School

Are you Dr. Burns?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 85 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    University of Minnesota Physicians
    516 Delaware Street SE PWB Fifth floor Clinic 5B
    Minneapolis, MN 55455
    Phone+1 612-273-2800
    Fax+1 612-625-6919

Summary

  • Dr. Linda Burns, MD is an oncologist in Minneapolis, Minnesota. She is currently licensed to practice medicine in Minnesota and Iowa. She is affiliated with M Health Fairview University of Minnesota Medical Center and is a Professor at University of Minnesota Medical School.

Education & Training

  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1984 - 1988
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1981 - 1984
  • University of Missouri-Columbia School of Medicine
    University of Missouri-Columbia School of MedicineClass of 1981

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 1992 - 2025
  • IA State Medical License
    IA State Medical License 1981 - 1994
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Leveling the Playing Field: Can We Achieve Gender Equality in Medicine?
    Leveling the Playing Field: Can We Achieve Gender Equality in Medicine?July 1st, 2018

Grant Support

  • Mt2005-06-A Randomized Phase II Study Of Zolendronic Acid (ZOMETA) In The PrevenNational Center For Research Resources2007–2009
  • 2008 Clinical Research Training Institute Summer WorkshopNational Heart, Lung, And Blood Institute2008
  • Mt2005-14-Phase I OPEN Label, Single Arm, Dose Escalation Trial To Evaluate TheNational Center For Research Resources2008
  • Mt2005-13-A Phase I OPEN Label, Single Arm, Dose Escalation Trial To Evaluate THNational Center For Research Resources2008
  • Mt2005-14-A Phase I OPEN Label, Single Arm, Dose Escalation Trial To Evaluate THNational Center For Research Resources2007
  • Mt2005-13-Phase I OPEN Label, Single Arm, Dose Escalation Trial To Evaluate TheNational Center For Research Resources2007
  • Mt-2002-05-Post-Transplant Immunotherapy With Interleukin-2 (Il-2) And RituximabNational Center For Research Resources2007
  • A Phase I OPEN Label, Single Arm, Dose Escalation Trial To Evaluate The BiodistrNational Center For Research Resources2006
  • Post-Transplant Immunotherapy With Interleukin-2 (Il-2) And RituximabNational Center For Research Resources2004–2006
  • A Phase I Study Of Ahn-12 In Patients With Advanced Leukemia/LymphomaNational Center For Research Resources2005